INCR
Price
$1.46
Change
+$0.02 (+1.39%)
Updated
Sep 26 closing price
Capitalization
79.59M
52 days until earnings call
PHCUF
Price
$5.87
Change
-$0.13 (-2.17%)
Updated
Aug 7 closing price
Capitalization
154.11M
Interact to see
Advertisement

INCR vs PHCUF

Header iconINCR vs PHCUF Comparison
Open Charts INCR vs PHCUFBanner chart's image
Intercure
Price$1.46
Change+$0.02 (+1.39%)
Volume$58.31K
Capitalization79.59M
Photocure ASA
Price$5.87
Change-$0.13 (-2.17%)
Volume$1K
Capitalization154.11M
INCR vs PHCUF Comparison Chart in %
Loading...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INCR vs. PHCUF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCR is a Buy and PHCUF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (INCR: $1.46 vs. PHCUF: $5.87)
Brand notoriety: INCR and PHCUF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INCR: 148% vs. PHCUF: 127%
Market capitalization -- INCR: $79.59M vs. PHCUF: $154.11M
INCR [@Pharmaceuticals: Generic] is valued at $79.59M. PHCUF’s [@Pharmaceuticals: Generic] market capitalization is $154.11M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCR’s FA Score shows that 1 FA rating(s) are green whilePHCUF’s FA Score has 1 green FA rating(s).

  • INCR’s FA Score: 1 green, 4 red.
  • PHCUF’s FA Score: 1 green, 4 red.
According to our system of comparison, PHCUF is a better buy in the long-term than INCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCR’s TA Score shows that 3 TA indicator(s) are bullish while PHCUF’s TA Score has 1 bullish TA indicator(s).

  • INCR’s TA Score: 3 bullish, 6 bearish.
  • PHCUF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, PHCUF is a better buy in the short-term than INCR.

Price Growth

INCR (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while PHCUF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

INCR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHCUF($154M) has a higher market cap than INCR($79.6M). PHCUF has higher P/E ratio than INCR: PHCUF (772.72) vs INCR (24.99). PHCUF YTD gains are higher at: 4.907 vs. INCR (-8.176).
INCRPHCUFINCR / PHCUF
Capitalization79.6M154M52%
EBITDAN/A44.5M-
Gain YTD-8.1764.907-167%
P/E Ratio24.99772.723%
RevenueN/A523M-
Total CashN/A239M-
Total DebtN/A0-
FUNDAMENTALS RATINGS
INCR vs PHCUF: Fundamental Ratings
INCR
PHCUF
OUTLOOK RATING
1..100
6445
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8792
PRICE GROWTH RATING
1..100
6445
P/E GROWTH RATING
1..100
56
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCR's Valuation (60) in the Servicestothe Health Industry industry is somewhat better than the same rating for PHCUF (98) in the null industry. This means that INCR’s stock grew somewhat faster than PHCUF’s over the last 12 months.

INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as PHCUF (100) in the null industry. This means that INCR’s stock grew similarly to PHCUF’s over the last 12 months.

INCR's SMR Rating (87) in the Servicestothe Health Industry industry is in the same range as PHCUF (92) in the null industry. This means that INCR’s stock grew similarly to PHCUF’s over the last 12 months.

PHCUF's Price Growth Rating (45) in the null industry is in the same range as INCR (64) in the Servicestothe Health Industry industry. This means that PHCUF’s stock grew similarly to INCR’s over the last 12 months.

INCR's P/E Growth Rating (5) in the Servicestothe Health Industry industry is in the same range as PHCUF (6) in the null industry. This means that INCR’s stock grew similarly to PHCUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INCRPHCUF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 6 days ago
25%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
28%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
32%
Advances
ODDS (%)
Bullish Trend 21 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
20%
View a ticker or compare two or three
Interact to see
Advertisement
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGRTX83.960.63
+0.76%
JPMorgan US Value R2
SVIFX9.500.07
+0.74%
Virtus Ceredex Large-Cap Value Equity C
RSGGX27.280.11
+0.40%
Victory RS Global A
ALIBX13.100.05
+0.38%
ALPS/Smith Balanced Opportunity Inv
IWTTX11.49N/A
N/A
Voya Global High Dividend Low Vol PortS2

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and PHCUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+1.39%
PHCUF - INCR
26%
Poorly correlated
N/A
TLRY - INCR
22%
Poorly correlated
-3.36%
QNTM - INCR
22%
Poorly correlated
-4.39%
DRRX - INCR
21%
Poorly correlated
N/A
CGC - INCR
21%
Poorly correlated
-2.19%
More

PHCUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HLTRF - PHCUF
38%
Loosely correlated
-0.78%
INCR - PHCUF
26%
Poorly correlated
+1.39%
ELAN - PHCUF
24%
Poorly correlated
+3.65%
MKKGY - PHCUF
22%
Poorly correlated
+0.81%
MKGAF - PHCUF
20%
Poorly correlated
+1.28%
More